Gabrielle Mazero
Lawyers
Filters
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055
S&P Global and CME Group $3.1 billion sale of OSTTRA to KKR
We are advising S&P Global on the transaction
Digicomm International acquisition of EasyStreet Systems
We advised Crestview Partners and Digicomm International on the transaction
Wayfair $700 million senior secured notes offering
The high-yield notes are due 2030
Tenaya Therapeutics $52.5 million units offering
The units comprise common stock and warrants
Horizon Mutual Holdings debut $600 million senior notes offering
The investment-grade notes are due 2034
First American Financial $450 million senior notes offering
The 5.45% investment-grade notes are due 2034
Illumina $500 million notes offering
The 4.65% investment-grade notes are due 2026
Generation Bio $237 million at-the-market offering
The shares are listed on Nasdaq